Shares of BIO-key International BKYI rose 7.9% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share were unchanged 0.00% over the past year to ($0.18), which missed the estimate of ($0.16).
Revenue of $1,064,000 higher by 98.95% year over year, which missed the estimate of $1,350,000.
Outlook
BIO-key sees FY21 sales of $8 million-$12 million.
Conference Call Details
Date: Mar 25, 2021
Time: 10:00 AM
ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=H795VkFj
Recent Stock Performance
52-week high: $5.17
52-week low: $0.37
Price action over last quarter: Up 13.16%
Company Profile
BIO-key International Inc a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. The company is organized into one principal operating segment - Biometric Products. Its product portfolio comprises SideSwipe, SideTouch, EcoID, Web-key, and ID director. The company generates its revenue in the form of License fees and others.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.